MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash and cashequivalents$56,129K Prepaid expenses andother current assets$1,439K Other receivables$44K Total current assets$57,612K Operating lease right ofuse assets$1,256K Other assets$153K Total assets$59,021K Total liabilities andstockholders' equity$59,021K Total stockholders'equity$52,934K Total liabilities$6,087K Accumulated deficit-$458,269K Additional paid-in capital$511,145K Total currentliabilities$5,489K Non-current operating leaseliabilities$507K Other long-termliabilities$91K Common stock, 0.001 parvalue 120,000,000...$58K Accrued expenses andother current...$3,142K Operating leaseliabilities$1,967K Accounts payable$217K Income taxes payable$163K
Balance Sheet

Spero Therapeutics, Inc. (SPRO)

Spero Therapeutics, Inc. (SPRO)

source: myfinsight.com